glp 1 pen Understanding GLP-1 medications The perils and promise of
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the management of type 2 diabetes and obesity, offering significant benefits in glycemic control and weight reduction

Villumsen M et al

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: a randomized, double-blind, placebo-controlled clinical trial protocol

it involves complex metabolic, hormonal, and lifestyle factors

doi: 10.1111/dom.12596 [DOI] [PMC free article] [PubMed] [Google Scholar] 94

In 2022, drugmakers inability to keep up with demand for GLP-1s opened the floodgates to compounded versions
